🇺🇸 FDA
Patent

US 8962297

Bacteriophage lytic enzymes as alternative antimicrobials

granted A61PA61P31/04

Quick answer

US patent 8962297 (Bacteriophage lytic enzymes as alternative antimicrobials) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P31/04